Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Sight Sciences, Inc.
Report date August 31, 2025 · Filed September 03, 2025
Section 16 reporting ended · disclosed 2025-09-03. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2025 Filed May 21, 2025 20:39 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 12,767 | $3.02 | $38,530.81 |
DisclosureSEC source: 0000950170-25-075990 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,767 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), that were acquired by the Reporting Person under the Sight Sciences, Inc. 2021 Employee Stock Purchase Plan ("2021 ESPP"). F2 · price: Reflects the price at which the shares were acquired under the 2021 ESPP, which is equal to 85% of the fair market value of the Common Stock on the last day of the offering period under the 2021 ESPP. Read SEC document |
| March 13, 2025 Filed Mar 13, 2025 21:51 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 10,000 | $2.60 | $26,000.00 |
DisclosureSEC source: 0000950170-25-039073 · ownership.xml · nonDerivative · entry 3 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,000 Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 21:51 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 10,000 | $2.73 | $27,250.00 |
DisclosureSEC source: 0000950170-25-039073 · ownership.xml · nonDerivative · entry 2 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $2.70 to $2.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:51 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039073 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in four equal annual installments commencing January 15, 2026 and continuing through January 15, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the greater of (i) the closing price of the Common Stock on the grant date, which was March 11, 2025, or (ii) $5.00, such that the total number of shares of Common Stock underlying the grant of RSUs would not exceed 24,000. The RSUs have no expiration date. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 18:16 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 5,000 | $3.85 | $19,250.00 |
DisclosureSEC source: 0000950170-24-134670 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,000 Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 20:18 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 3,376 | $3.89 | $13,132.64 |
DisclosureSEC source: 0000950170-24-133809 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,000 Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 18:40 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 4,624 | $3.99 | $18,440.51 |
DisclosureSEC source: 0000950170-24-132978 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,624 F1 · price: Reflects the weighted average price at which the shares of the Issuer's common stock, par value $0.001 per share, were purchased. The shares were purchased in multiple transactions at prices ranging from $3.97 to $3.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:18 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | PurchaseCommon Stock | 2,000 | $3.70 | $7,400.00 |
DisclosureSEC source: 0000950170-24-129888 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,000 Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 21:51 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 96,000 | $4.59 | $440,640.00 |
DisclosureSEC source: 0000950170-24-128221 · ownership.xml · nonDerivative · entry 1 Raheja Manohar K. · CIK 0002042497 · EVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,000 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in four equal annual installments commencing November 15, 2025 and continuing through November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.